#398 What’s 340B? An Economist’s View of the Recent Wave of 340B Litigation
The Federal 340B Drug Pricing Program has grown from a modest drug discount program into […]
#397 What’s Next for the ABA Antitrust Law Section? Stability, Balance, and Value
What’s ahead for the ABA Antitrust Law Section in 2026–2027? Section Chair Melanie Aitken and […]
#396 Is EU Law on Abuse of Dominance Now Clear? The ECJ’s Judgment in Google Android
The European Court of Justice’s judgment in Google Android is one of the most consequential […]
#395 Which Side of the V? Larry Buterman on Trying Antitrust Cases for the Government and Against It
Larry Buterman is one of the rare antitrust attorneys who has successfully first chaired landmark […]
#394 A Tribute to Randy Picker: Revisiting Episode #74 on the Implications of DOJ’s Case Against IBM
We are re-releasing this episode in tribute to Prof. Randy Picker, who passed away on […]
#393 Who Gets To Say the Price Is Right? State Regulation of AI Pricing
Several U.S. states have recently passed legislation aimed at AI pricing tools that use consumer […]
#392 Do I Really Need To File? HSR Avoidance and the Edwards/Genesis Settlement
For nearly 50 years, the Hart-Scott-Rodino Act has given antitrust enforcers a chance to review […]
#391 Have States Found the Answer to Subscription Traps? Click-to-Cancel and Beyond
State legislatures across the country are taking aim at subscription traps and deceptive cancellation practices […]
#390 Circuits, Cargos, and Cures: How Does Singapore Run Competition and Consumer Protection?
Singapore’s Competition and Consumer Commission — CCS — has been enforcing competition law for roughly […]
#389 What Should Directors Be Asking? Antitrust in the Boardroom
Competition law isn’t just for antitrust lawyers anymore—it’s increasingly a boardroom issue. What questions should […]